Načítá se...
Inhaled therapy in cystic fibrosis: agents, devices and regimens
KEY POINTS: There have been significant advances in both inhalation medicines and delivery devices with “intelligent nebulisers” and “dry-powder inhalers” becoming commonplace in CF care. Inhaled medicines generate high levels of a drug within the airways with limited systemic effects, offering safe...
Uloženo v:
| Vydáno v: | Breathe (Sheff) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
European Respiratory Society
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4487378/ https://ncbi.nlm.nih.gov/pubmed/26306111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.021014 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|